Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs CBRE✓SelectedUSD · CBREGSK vs CBRE performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs CBRE

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+7.3%
CBRE return
-17.3%
Excess return
+24.5%
Maximum drawdown
-22.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioCBREExcessAlpha
1D-0.1%-1.2%+1.1%+0.1%
7D-5.3%-4.8%-0.5%-4.4%
30D-3.7%-5.9%+2.2%-2.4%
3M-7.3%-16.5%+9.3%-3.9%
6M-4.2%-3.4%-0.9%-3.3%
YTD+0.9%-21.2%+22.1%+3.6%
1Y+7.3%-16.4%+23.7%+7.9%
All+7.3%-17.3%+24.5%+7.9%

Cumulative growth

Daily Returns

Daily percentage return beside CBRE.

Daily Out/Under-Performance

Portfolio return minus CBRE return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CBRE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded CBRE wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling